Godolphin’s Epsom Hopes Crash as Cameo Stuns Romantic Symphony in Lingfield Oaks Trial

The mounting anxiety surrounding Charlie Appleby’s Godolphin yard became a harsh reality on Saturday afternoon. Aidan O’Brien’s 12-1 longshot Cameo, piloted by jockey Ryan Moore, surged to a decisive victory in the Lingfield Oaks Trial. They completely shut down the heavily backed favourite Romantic Symphony.

Earlier in the day, ITV Opening Show pundit Leonna Mayor raised a “huge concern” regarding Appleby’s sudden 0-20 slump heading into the weekend, according to the Racing Post live raceday coverage. Appleby entered the May 9 trials fielding multiple short-priced, single-figure favourites across the board. The fear surrounding his unbeaten runners proved completely justified when Cameo crossed the finish line first.

These Saturday races act as an essential proving ground. They test a horse’s balance and stamina on a tricky downhill sweep that mirrors the iconic Epsom track. The pressure was intense for previously unbeaten Classic contenders like Romantic Symphony and Maho Bay. But when the gates opened, the market confidence fractured against the official field of competitors and starting odds in the William Hill Oaks Trial Fillies’ Stakes.

For fans tracking global sports, this Godolphin collapse changes the entire momentum of the spring racing season.

What the Godolphin Collapse Means for Aidan O’Brien at Epsom

Appleby’s yard historically dominates these spring trials. During this exact same two-week window last year, the stable operated at a highly efficient 7-18 success rate. The current 0-20 drought represents an unexpected vulnerability in the usually flawless Godolphin spring preparation strategy.

O’Brien and Moore immediately capitalized on that weakness. Cameo’s win forces betting markets to drastically re-evaluate their Epsom odds. With Romantic Symphony failing her first major stamina test, rival syndicates are now seizing the momentum to build confidence for their own Epsom Derby and Oaks campaigns.

Recent Articles

Related News

Leave A Reply

Please enter your comment!
Please enter your name here